chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, dizziness, naseua, fever, food stayed in stomach for 24 hours, chills, hot flashed, muscle aches, fatigue no reactions prior to 2007. However 2007, 2008, 2009 same reaction-2007 worse, 2008 not as bad, 2009 moderate.
Thursday 4/15/21 7pm: out of no where, marked increase in thirst/urination and dry mouth, tip of tongue numbing. Increased breathing/heart rate, random body chill and clammy handswith some tingling . Lasted ~1-2 hours. Friday 4/16/21: intermittent episodes of the same described above throughout day. Saturday 4/17/21: still experincing intermittent episodes, went to urgent care for exam as for 20 minutes hard to catch breath [was having anxiety at this point]. Calmed down and nothing foumd on exam. Sunday 4/18/21 still feeling off, but syptoms less intense. Monday 4/19/21 felt more normal, then had episode of vision spotting then complete blurriness in left eye for 10 minutes, followed by head pressure/headache for couple hours. Tuesday 4/20/21. Mild dry mouth all day and some jaw soreness in evening. Wednesday 4/21/21 felt normal all day. Thursday 4/22/21 sinus pressure for few hours/head congestion and dry mouth again. Today 4/23/21, still mild dry mouth.
2:15PM      headache  10:30PM.   Rash and itch on face trunk and under arms                            Dry scratchy eyes , hazy vision Took Benadryl 25 mg at 10:45PM 1/15/2021.  9AM  Rash subsided itch persists and eyes remain dry, scratchy and hazy vision gone                             10 AM went to Dr
Fluzone vaccine administered on the afternoon of 10-13-14. No Rxn noted - child awoke the next day with hives "all over". Symptoms only lasted a few days.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 31-AUG-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9, 0.5 ml injection, lot # L007495 with expiration date 24-FEB-2017 (route and dose were not reported). This specified lot number vaccine was exposed to temperature excursion twice. The storage criteria was refrigerator (R). The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) were as following: for the first excursion was 24, 33 and R; for the second excursion was 224, 31 and R. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Vesicular rash in umbilical area followed by lesions on chest and finally on bilateral forearms. Rash is very pruritic.
Patient received shots on 4-14-09.  Returned to clinic on 4-17-09 with report of swelling in right arm and face and itching starting on Tuesday night.
RN witnessed the allergic reaction but was unable to get employee to EHS as the employee wanted to go home instead.
ALMOST DIED; This spontaneous report received from a patient via social media  via company representative concerned a male of an unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration was not reported, batch number: unknown, and expiry date: unknown) dose, start therapy date were not reported, 01 total was administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient (reporter's neighbour) experienced almost died, On an unspecified date, the patient got vaccine and he ended up in Intensive care unit (ICU) for almost 2 weeks. The patient stated that he will not get the booster and going to take his chances. It was reported by reporter that "My neighbour got the JJ vaccine. He ended up in ICU for almost 2 weeks. Almost died...he said he will not get the booster and going to take his chances". On an unspecified date he was hospitalized. Number of days hospitalized and discharge information was not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of almost died was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0 20220224229-COVID-19 VACCINE AD26.COV2.S-Almost died. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
One month later developed face and neck reaction. Face and neck developed severe histamine response, redness, itchiness, swollen eyes after 3 days of that skin started peeling and redness and swollen eyes slowed and peeling finally stopped in two weeks. One week after that another reaction happened. Reactions have been happening ever since stemming from all different things that I've never had issues with before.
This is 39 weeks +2 gestation baby boy, S/P NSVD, came to check up and received the 2nd dose of hepatitis B vaccine 3 days ago. Right after injection grandma brought baby back to Dr. PCP and complaint baby's face turned pale with less active. Dr. checked the patient's heart rate that was regular. Dr. examined the patient and then the patient cried and face turned to red. It was about 5 minutes. Dr. asked mother to feed baby with bottle formula. The patient's suction was strong. After feeding (2 OZs) baby fell sleep and face color maintained normal. Dr. discharged the baby home afterwards. Dr. made a follow-up call 2-3 hours later. Mother said baby is OK, just quiet than before. The following night mother saw patient rolling his eye and went to Hospital - ER. ER attending discharged him home the same day. Last night patient had eye rolling episodes again. No fever, respiratory distress, no seizure noticed. Bottle feeding 2 OZs every 2 hours. Stool once a day. Mother complained that patient's extremities feel cold and look pale than before. I checked patient big toe O2 sat: 100% on room air. Pals: 150-160. Mother said patient did not sleep well last night and sleep day time now.The following night mother saw patient rolling his eye and went to ER. ER attending discharged him home the same day. Last night patient had eye rolling episodes again. No fever, respiratory distress, no seizure noticed. Bottle feeding 2 OZs every 2 hours. Stool once a day. Mother complained that patient's extremities feel cold and look pale than before. Dr. checked patient big toe O2 sat: 100% on room air. Pals: 150-160. Mother said patient did not sleep well last night and sleep day time now.
Migraine beginning the next day in the afternoon, lasted 24 hours. Elevated blood pressure in the evening of 3/30 as well.
Patient said that he felt increasing discomfort within 4 to 5 inches from injection site.  Injection given 9/19/2021, reaction reported to pharmacy 11/16/2021.  I recommended that the patient use benadryl and ice pack and to have a physician look at it.
Cellulitis of left arm seen at ER on 11-08-15 had MRI of left upper extremity, blood work, meds cetirizine, clindamycin, cefdinir.
One month post vax the patient developed protracted emesis. There was no fever or rash. The patient became atoxic (clumsy) 3 days later. There was no evidence of Otitis Media when seen by the ENT. Symptoms resolved 09/30/2001 per mother.
chills; Fatigue; Some shortness of breath; Very slight headache; slight nausea; This is a spontaneous report received from a contactable consumer. This 85-year-old female consumer (patient) reported in response to Non-HCP letter sent in cross reference case. Patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot: EN6203, Expiration date not reported) via intramuscular route on upper Left arm on 24Feb2021 at 07:15 A.M single dose for COVID-19 immunisation. Patients medical history included Pain, swelling in left wrist from 15Nov2020 (ongoing, doctor suggested wrist brace and ibuprofen when needed) and on 15Feb2021, the patient had Pain still in wrist (ongoing, was given injection of 40mg, Kenalog eased pain immediate). Patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot: EL9264) via intramuscular route on upper Left arm on 03Feb2021 at 09:40 A.M as single dose for Covid-19 immunization and experienced pain in wrist. The patient's concomitant medications were not reported. Patient experienced in reaction to vaccine was chills, fatigue, some shortness of breath, very slight headache, slight nausea on unspecified date. Outcome of event was reported was reported as unknown.  Follow-up (15Mar2021): The initial case was missing the following minimum criteria: No adverse effect. Upon receipt of follow-up information on (15Mar2021), this case now contains all required information to be considered valid.
Information has been received from a physician concerning an 18 year old female who was vaccinated with the first dose of GARDASIL. Per the reporter, the patient experienced a bad rash at the injection site that lasted a few days and felt ill. Subsequently, the patient recovered from the bad rash at the injection site and feeling ill. The patient sought unspecified medical attention. The patient's mother decided that the patient would not go on to receive the second and third doses. No further information was provided. Additional information has been requested.
My husband and I took a trip on April 15, 2022 which is probably where we got our exposure. We did use masks but we ate at crowded restaurants several times. On Sunday, my husband started to experience symptoms and he did an At-home test on Monday, April 18 and came back positive and confirmed with a PCR test. He was symptomatic and we did our best and I still did not avoid infection either from exposure over the weekend or exposure from him. I began testing myself every 2 days starting on the 18 of April. I was symptomatic on Wednesday April 20, and tested myself but still came back negative. The symptoms I felt were fatigue, head congestion which was very much like bad allergy symptoms. Mild diarrhea which was a slight disruption from usual GI patterns. I believe I felt a little better on the 23rd then felt bad on the 24th again. I finally got a positive test on the 24th. Because I have asthma and approaching 65 years old and I knew Paxlovid was available, I sought out help from a clinic on Sunday the 24th. They did a PCR test. I also looked into government testing, and I was referred to a pharmacy. And the timing was off, so I was looking to see if I was still eligible for Paxlovid. I was able to make the window and I was able to take Paxlovid on April 25-29. My respiratory and GI symptoms started abating around the 27th. They were pretty much gone by that point. I still experience some fatigue that?s unusual for me. Less frequency over the month. At first I would even get tired running up the stairs and I haven?t been able to resume my exercise routine. I have been wanting to take naps, but that?s lessening as well. During the time when I had more symptoms from COVID, I had one day where I slept all day. Main symptoms were fatigue (moderate) and other symptoms such as respiratory and GI were mild. I would say I?m almost recovered but not fully. Around 90-95% recovered.
72 HRS AFTER INJECTION C/O PAIN TO ARM ESPECIALLY WHEN TRYING TO RAISE IT, CALLED CLINIC W/COMPLAINTS 5 DAYS LATER, INSTRUCTED TO GIVE OTC NSAIDS & APPLY COMPRESSES ALTERNATING WARM & COOL, ROM. IF NO IMPROVEMENT F/U W/PMD. 12 DAYS LATER CALLED CLINIC AGAIN. GIVEN SAME INSTRUCTIONS. CHECKED ON PATIENT 3 WEEKS POST INJECTION, NOT VERBALIZING COMPLAINTS ANY FURTHER.
Mid afternoon - sore throat and cough. 6:00 PM -  aches. 6:30 PM - uncontrollable shaking - lasted ten minutes, followed by aches and chills for rest of the night.  By morning, felt washed out with most of aches and chills subsided.
Periorbital edema of left eye, rash around mouth- 1:04 Epi pen administered R thigh - 1:05  EMS called. Pt refused trasnport.
This spontaneous report was received from a registered nurse via company representative refers to a 42 year old male patient. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX, (lot number and expiry date was not reported, route was subcutaneous). Concomitant medications were not reported. On an unknown date, the nurse reported that the patient was administered ZOSTAVAX in his abdomen which was other than indicated in the prescribing information and experienced swelling and red mark in the abdomen area and a slight fever. The nurse also confirmed that the patient was 42 years old and was administered ZOSTAVAX which was other than indicated in the prescribing information. There was no lab diagnostics studies performed. On an unknown date, the patient recovered from the reported events. It was unspecified if the patient sought medical attention. Additional information has been requested.
Stiff neck, gas, nausea, shivering, fever, from about 10:45 pm to 5:30 am
High fever by 37.9 degrees; Some inflammation in my throat; Muscle pain; I feel physically weak now; I got the third shot of Pfizer COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administration date 07Oct2021 14:00 (Batch/Lot number: unknown) as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: Apr2021, for Covid-19 immunization; Bnt162b2 (Dose 2), administration date: Apr2021, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 07Oct2021 14:00, outcome "unknown", described as "I got the third shot of Pfizer COVID-19"; PYREXIA (non-serious) with onset 08Oct2021, outcome "unknown", described as "High fever by 37.9 degrees"; PHARYNGEAL INFLAMMATION (non-serious) with onset 08Oct2021, outcome "unknown", described as "Some inflammation in my throat"; MYALGIA (non-serious) with onset 08Oct2021, outcome "unknown", described as "Muscle pain"; ASTHENIA (non-serious) with onset 08Oct2021, outcome "not recovered", described as "I feel physically weak now". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient claims to have experienced serious side effects/problems and was asking for advice.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
small heart attack; myocardial/paracardial issues.; My injection location had redness, hardness; My injection location had redness, hardness; pains in chest; headache; chill; running nose; shortness of breath.; This is a spontaneous report from a contactable consumer (patient). A 44-years-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 19Feb2021 17:45 at single dose for COVID-19 immunisation at hospital. Medical history included coronary artery disease. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2 on unknown date for covid-19 immunisation. The patient did not have covid before vaccination. The patient experienced small heart attack and myocardial/paracardial issues on an unspecified date with outcome of unknown. These events were serious as life threatening, disability and requiring hospitalization from 21Feb2021 till 23Feb2021 at 14:00. On 20Feb2021 07:00 the patient experienced headache, chill, running nose, shortness of breath with outcome of recovering. The patient experienced also pains in chest on 21Feb2021 11:00 with outcome of recovering and injection location had redness, hardness on an unspecified date with outcome of recovering. Clinical course was as follows. 19Feb2021-5:45pm the patient went to receive vaccine shot. 20Feb2021 the patient had headache, chill, runny nose, and shortness of breath. 21Feb2021 11am still had shortness of breath and pains in chest. Went to clinic had a rapid Covid test come back negative, pain increased and he went to emergency room. The patient was admitted to the hospital with small heart attack and myocardial/paracardial issues. Inflammatory response seems to possibly triggered possible underlying issue of minor heart disease. Then induced heart attack and myocardial issue. The patient would gladly be admitted to a clinic for observation and testing to assist Pfizer in understanding this unfortunate situation. The injection location had redness, hardness. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received treatment due to the event which included multiple lab tests, Angiogram, CR scan and pain medicine.
dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021 at 9:28 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 9:28 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 66.09.  Concomitant products were not provided.  On 31-Mar-2021, Excursion time was 08 AM, temperature was 32, total doses given for the day was 199, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 31-Mar-2021. 4 vials was sent to clinic. Vaccine BUD dates was22-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
cannot get well; got very sick; fever 103F; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (cannot get well), ILLNESS (got very sick) and PYREXIA (fever 103F) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (cannot get well), ILLNESS (got very sick) and PYREXIA (fever 103F). At the time of the report, MALAISE (cannot get well), ILLNESS (got very sick) and PYREXIA (fever 103F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not reported.   Reporter did not allow further contact
Pt experienced localized swelling, erythema, febrile, malaise, myalgia all over.
PATIENT VISITED URGENT CARE WITH SYMPTOMS, WAS TOLD BY MD THAT SHE HAD CELLULITIS
swollen lips; swollen tongue; numb lips; numb tongue; This spontaneous case was reported by a nurse and describes the occurrence of LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), HYPOAESTHESIA ORAL (numb lips) and PARAESTHESIA ORAL (numb tongue) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for an unknown indication.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), HYPOAESTHESIA ORAL (numb lips) and PARAESTHESIA ORAL (numb tongue). At the time of the report, LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), HYPOAESTHESIA ORAL (numb lips) and PARAESTHESIA ORAL (numb tongue) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Follow up received on 14-APR-2021Included Reporter details , Age
Left deltoid immediately swelled once flu vaccine was administered. Ice pack given. (Pt) said he was okay and insisted on returning to his desk
onset of internal itching; followed by pressure and itching behind her eyes had some mild shortness of breath while walking;  headache temp 99.8;  elevated B/P  178/97; HR 102 TX:   Benadryl 25mg p.o.;  Ibuprofen 400mg p.o.; rest
Fever 101, chills, nausea, body aches, headache, vertigo, dizziness, fatigue; lasted 24 hours. Dizziness is ongoing though.
pt recv vax & exp chickenpox & devel about200 generalized vesicles;pt broke out for 6 days w/a low grade fever @ days 2 & 3;
This spontaneous report was received via a company representative from a 65 year old female nurse practitioner who was also the patient. On 10-OCT-2013, the patient was vaccinated with a single dose injection of ZOSTAVAX (dose and therapy route were not reported). Patient was not taking any concomitant medications. In October 2013, the patient developed a painful rash after receiving the ZOSTAVAX. It was reported that this rash was "on the trunk of her body" and she was using acyclovir for treatment. The patient also received an "unspecified steroid injection" in her neck 4 days after receiving the ZOSTAVAX. At the time of the report the patient was recovering from the painful rash. The relationship between the painful rash and therapy with ZOSTAVAX was not reported. Additional information has been requested.
SOB, anxiety, restlessness  Patient couldn't calm down.  Felt like she had a lump in her throat.